Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.
The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Three more Kovsie staff members involved in Olympic Games
2012-05-30

 

Dr Derik Coetzee
Photo: Supplied
30 May 2012

The South African men’s hockey team will practice on our Bloemfontein Campus from 28 May to 8 June 2012, and the team count on the assistance of three Kovsies to prepare them for the Olympic Games taking place in London later this year.  

Dr Derik Coetzee, senior lecturer in the Department of Exercise and Sport Science and Head of our High Performance Centre, has been appointed conditioning coach of the team. He will be assisted by Colleen Jones and Riaan Schoeman, also from this department.

The UFS team and Mr Gregg Clark, the team’s coach, will work out a periodisation programme for the team, which will continue until the hockey finals at the Olympic Games. The programme includes the correct exercises, volume, intensity and number of exercise sessions per week.

This is not the first time that Dr Coetzee has assisted sports teams to prepare for important events. In 2007, he was the conditioning coach of the Springbok rugby team that won the World Cup in France. He was also the conditioning coach of the under-21 Springbok team in 2002 that won the Junior World Cup Tournament. 

Dr Coetzee says it is a challenge to ensure that the team performs well at the Olympic Games. “The joy on the faces of the coach and players when they qualified in Japan cannot be described because many people thought they would not qualify.”

With the addition of Dr Coetzee, Ms Jones and Mr Schoeman, a total of six staff members from the UFS will be involved with the Olympic Games and the Paralympic Games. The other three are:

  • Dr Louis Holtzhausen, Head of the university’s Department of Sports and Exercise Medicine, has been selected as team doctor for the more than 300 athletes that will represent South Africa at this year’s Olympic Games (in London).
  • Ms Ebeth Grobbelaar, Assistant Director of the South African Testing Laboratory for Prohibited Substances at the UFS, was invited to be involved in the Drugs Control Centre in the unit against prohibited substances which will test sportsmen and -women during the games.
  • Ms Hetsie Veitch, Head of the Unit for Students with Disabilities, has been invited to be a member of the Classification Panel at the final USA Paralympic athletics trials.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept